CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of EB103 T-Cell Therapy in Adults With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06343311
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:29.799318+00:00
Published At: 2025-08-07T00:00:00+00:00
Record Updated At: 2025-08-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["B-Cell Non-Hodgkin\u0027s Lymphoma (NHL)", "Lymphoma, Non-Hodgkins", "Lymphomas Non-Hodgkin\u0027s B-Cell", "Non-Hodgkin Lymphoma", "Non-Hodgkin\u0027s Lymphoma", "Large B-Cell Lymphoma", "Lymphoma, Non-Hodgkin\u0027s, Adult", "Lymphoma", "Refractory Non-Hodgkin Lymphoma", "Relapsed Non-Hodgkin Lymphoma", "Lymphoma, Non-Hodgkin", "HIV Associated Lymphoma", "CNS Lymphoma", "High-grade B-cell Lymphoma", "Refractory B-Cell Non-Hodgkin Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-07"
protocolSection.identificationModule.nctId: "NCT06343311"
protocolSection.identificationModule.officialTitle: "An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of EB103 T-Cell Therapy in Adults With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin\u0027s Lymphoma (NHL)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.